ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman

February 25, 1994

National Dialogue On Cancer, The Cancer Act, And Activism.

February 4, 2000

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

In Brief: Glick, Armitage Lead ASCO; NCAB Approves Resolution Calling For Higher NIH Budget

June 2, 1995